Close

Wells Fargo Downgrades Global Blood Therapeutics (GBT) to Equal Weight

August 9, 2022 5:29 AM EDT
Get Alerts GBT Hot Sheet
Price: $68.49 --0%

Rating Summary:
    12 Buy, 15 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 12 | Down: 16 | New: 15
Join SI Premium – FREE

Wells Fargo analyst Jim Birchenough downgraded Global Blood Therapeutics (NASDAQ: GBT) from Overweight to Equal Weight with a price target of $68.50 (from $66.00).


For an analyst ratings summary and ratings history on Global Blood Therapeutics click here. For more ratings news on Global Blood Therapeutics click here.


Shares of Global Blood Therapeutics closed at $66.60 yesterday.


You May Also Be Interested In





Related Categories

Analyst PT Change, Downgrades